Amedeo Smart

Free Medical Literature Service

 

Amedeo

Pancreatitis
  Free Subscription

Articles published in
Br J Surg
    October 2026
  1. VISSERS PAJ, Schoorlemmer A, Pek CJ, Appelhof P, et al
    Gastrointestinal symptoms and health-related quality of life before and after pancreatectomy for pancreatic cancer (GO-PANC): longitudinal nationwide study.
    Br J Surg. 2026;113:znag122.
    >> Share

    August 2026
  2. LI Z, Campbell BA, Molin MD, Song Y, et al
    Integrated driver gene-based survival prediction in resected pancreatic cancer.
    Br J Surg. 2026;113:znag123.
    >> Share

  3. HOPSTAKEN JS, Stommel MWJ
    A paradox in the quality of care in centralization of pancreatic cancer surgery.
    Br J Surg. 2026;113:znag092.
    >> Share

    June 2026
  4. STOOP TF, Seelen LWF, van 't Land FR, Scheepens JCM, et al
    Surgical Outcomes from Nationwide Implementation of the International Best-Practice for Locally Advanced Pancreatic Cancer (PREOPANC-4) study.
    Br J Surg. 2026 Jun 22:znag075. doi: 10.1093.
    >> Share

    May 2026
  5. DREYER SB, Bryce A, Froeling F, Jackson S, et al
    Clinical and molecular landscape of surgically resected early onset pancreatic cancer.
    Br J Surg. 2026;113:znag032.
    >> Share

    March 2026
  6. HALLET J, Falconi M, Buerba GA, Clarke C, et al
    BJS commission on the surgical management of pancreatic neuroendocrine tumours.
    Br J Surg. 2026 Mar 17:znag026. doi: 10.1093.
    >> Share

  7. HUGHES A, Matti J, Rehman-Wood A, Bond-Smith G, et al
    Pancreaticobiliary side effects of GLP1 agonists: A meta-analysis of published randomised control trials and a real-world pharmacovigilance profile.
    Br J Surg. 2026 Mar 5:znag022. doi: 10.1093.
    >> Share

    November 2025
  8. STRIJBOS BTM, Kraakman I, Hopstaken JS, van Dongen JC, et al
    Delayed gastric emptying after pancreatic cancer surgery impacts time to start of adjuvant treatment but not overall survival: a post-hoc analysis of the PREOPANC-1 and -2 trials.
    Br J Surg. 2025;112:znaf261.
    >> Share

  9. MENSO JE, Bruna CL, Ali M, Bonsing B, et al
    Oncological outcome after robot-assisted versus open pancreatoduodenectomy for upfront resectable cancer in the pancreatic head: a nationwide cohort analysis.
    Br J Surg. 2025;112:znaf153.
    >> Share

    October 2025
  10. PERRI G, Ribeiro T, Maekawa A, Dall'Olio T, et al
    Blood loss during pancreatic surgery: defining minimal clinically significant difference using standardized estimation.
    Br J Surg. 2025;112:znaf215.
    >> Share

  11. MAJALA S, Elonen L, Kaprio T, Vesterinen T, et al
    Predictors of long-term survival for patients with pancreatic neuroendocrine neoplasm in FinPanNET: nationwide biobank study with histopathological re-evaluation.
    Br J Surg. 2025;112:znaf197.
    >> Share


  12. Acute pancreatitis national audit of practice: a national prospective audit of acute pancreatitis in the era of GLP-1 agonists-the PANDORA audit protocol.
    Br J Surg. 2025;112:znaf214.
    >> Share

    September 2025
  13. SINGH M, Lucocq J, Vale L, Pandanaboyana S, et al
    Acute pancreatitis management in England: health and economic burden.
    Br J Surg. 2025;112:znaf200.
    >> Share

    August 2025
  14. KNOPH CS, Pandanaboyana S
    Pain intensity and prognosis of acute pancreatitis in an international, prospective study.
    Br J Surg. 2025;112:znaf155.
    >> Share

    July 2025
  15. STOOP TF, Rompen IF, Ali M, Groot Koerkamp B, et al
    Resectability stages of pancreatic cancer: nationwide reference.
    Br J Surg. 2025;112:znaf120.
    >> Share

    April 2025
  16. ADACHI Y, Okabe H, Hayashi H, Tagayasu Y, et al
    Round ligament coverage with polyglycol acid mesh and fibrin glue on pancreatic stump may decrease postoperative pancreatic fistula in distal pancreatectomy.
    Br J Surg. 2025;112:znaf101.
    >> Share

    March 2025
  17. HUANG H, Xu D, Huang J
    Laparoscopic spleen-preserving pancreatic tail resection: innovative surgical techniques and strategies.
    Br J Surg. 2025;112:znaf069.
    >> Share

  18. FRANCKEN MFG, Boxhoorn L, van Dijk SM, van Grinsven J, et al
    Cost-effectiveness of immediate versus postponed intervention for infected necrotizing pancreatitis: planned secondary analysis of the POINTER trial.
    Br J Surg. 2025;112:znaf071.
    >> Share

  19. VAN VELDHUISEN CL, Leseman CA, De Rijk FEM, Marques-Antunes J, et al
    Surgery for chronic pancreatitis across Europe (ESCOPA): prospective multicentre study.
    Br J Surg. 2025;112:znaf068.
    >> Share

  20. TANAKA H, Sakai A, Suenaga M, Hayashi M, et al
    FUT2 and FUT3-specific normalization of DUPAN-2 and carbohydrate antigen 19-9 in preoperative therapy for pancreatic cancer: multicentre retrospective study (GEMINI-PC-01).
    Br J Surg. 2025;112:znaf049.
    >> Share

  21. LIN H, Ning J, Liu Q, Du X, et al
    Application of transmesocolon pancreatic intestinal anastomosis in duodenal-preserving pancreatic head resection: video article.
    Br J Surg. 2025;112:znaf084.
    >> Share

  22. BONSDORFF A, Kjeseth T, Kirkegard J, de Ponthaud C, et al
    International multicentre validation of the left pancreatectomy pancreatic fistula prediction models and development and validation of the combined DISPAIR-FRS prediction model.
    Br J Surg. 2025;112:znae313.
    >> Share

    February 2025
  23. SHIRAISHI Y, Hayashi H, Liu Z, Schrader J, et al
    YAP/TAZ overexpression activates mTOR and Erk1/2 signalling and is associated with worse outcomes for patients with pancreatic neuroendocrine neoplasms.
    Br J Surg. 2025;112:znaf006.
    >> Share

  24. VAN SANTVOORT H, Voermans RP, Zyromski NJ, Siriwardena AK, et al
    Antibiotic stewardship in acute pancreatitis.
    Br J Surg. 2025;112:znaf007.
    >> Share

  25. WISMANS LV, Hendriks TE, Suurmeijer JA, Nuyttens JJ, et al
    Preoperative stereotactic radiotherapy to prevent pancreatic fistula in high-risk patients undergoing pancreatoduodenectomy (FIBROPANC): prospective multicentre phase II single-arm trial.
    Br J Surg. 2025;112:znae327.
    >> Share

  26. DEKKER EN, van Klaveren D, Verkolf EMM, de Wilde RF, et al
    Carbohydrate antigen 19-9 (CA19-9) response after induction FOLFIRINOX for locally advanced pancreatic cancer identifies patients who may benefit from surgical exploration: multicentre, observational cohort study.
    Br J Surg. 2025;112:znaf011.
    >> Share

  27. KLEIVE D
    Reducing pancreatic fistula after left-sided pancreatectomy-the search continues.
    Br J Surg. 2025;112:znaf033.
    >> Share

  28. SUMIYOSHI T, Uemura K, Seo S, Fujii T, et al
    Impact of pre-compression versus non-compression before parenchyma transection in left-sided pancreatic resection on the rate of clinically relevant pancreatic fistula: multicentre randomized clinical trial.
    Br J Surg. 2025;112:znaf008.
    >> Share

    December 2024
  29. DENG Z, Lan Z, Zhu H, Ren H, et al
    Metagenomic next-generation sequencing for the detection of bacterial translocation in the blood of patients following liver, biliary tract or pancreatic surgery.
    Br J Surg. 2024;112:znae326.
    >> Share

    October 2024
  30. LUCOCQ J, Pandanaboyana S
    Pancreatic cancer arising in intraductal papillary mucinous neoplasms (IPMN): emerging data warrants further research.
    Br J Surg. 2024;111:znae238.
    >> Share

  31. DEKKER EN, Narayan RR, Ahmami MA, Meddouch A, et al
    Chemotherapy switch for localized pancreatic cancer: a systematic review and meta-analysis.
    Br J Surg. 2024;111:znae244.
    >> Share

    August 2024
  32. PARTELLI S, Landoni L, Bartolomei M, Zerbi A, et al
    Neoadjuvant 177Lu-DOTATATE for non-functioning pancreatic neuroendocrine tumours (NEOLUPANET): multicentre phase II study.
    Br J Surg. 2024;111:znae178.
    >> Share

  33. HALLET J, Soreide K
    Neoadjuvant therapy with peptide receptor radionuclide therapy for pancreatic neuroendocrine tumours.
    Br J Surg. 2024;111:znae183.
    >> Share

  34. BRUNA CL, van Hilst J, Esposito A, Kleive D, et al
    The value of splenectomy during left-sided pancreatectomy for pancreatic ductal adenocarcinoma: predefined subanalysis in the DIPLOMA randomized trial.
    Br J Surg. 2024;111:znae236.
    >> Share

  35. SOREIDE K, Barreto SG, Pandanaboyana S
    Severe acute pancreatitis.
    Br J Surg. 2024;111:znae170.
    >> Share

    May 2024
  36. SISSINGH NJ, de Rijk FEM, Timmerhuis HC, Umans DS, et al
    Gallstones as a cause in presumed acute alcoholic pancreatitis: observational multicentre study.
    Br J Surg. 2024;111:znae107.
    >> Share

    April 2024
  37. UNDERWOOD PW, Cloyd JM
    Comment on: Predictive value of baseline serum carbohydrate antigen 19-9 level on treatment effect of neoadjuvant chemoradiotherapy in patients with resectable and borderline resectable pancreatic cancer in two randomized trials.
    Br J Surg. 2024;111:znae085.
    >> Share

  38. VAN RAMSHORST TME, van Hilst J, Boggi U, Dokmak S, et al
    Standardizing definitions and terminology of left-sided pancreatic resections through an international Delphi consensus.
    Br J Surg. 2024;111:znae039.
    >> Share

  39. ANDREASI V, Partelli S, Schiavo Lena M, Muffatti F, et al
    Prognostic significance of nodal micrometastases of non-functioning pancreatic neuroendocrine tumours.
    Br J Surg. 2024;111:znae076.
    >> Share

    March 2024
  40. THEIJSE RT, Stoop TF, Janssen QP, Prakash LR, et al
    Impact of a non-therapeutic laparotomy in patients with locally advanced pancreatic cancer treated with induction (m)FOLFIRINOX: Trans-Atlantic Pancreatic Surgery (TAPS) Consortium study.
    Br J Surg. 2024;111:znae033.
    >> Share

  41. IMAMURA T, Ashida R, Urakami K, Ohshima K, et al
    Comprehensive sequencing of circulating tumour DNA in resectable pancreatic cancer.
    Br J Surg. 2024;111:znae059.
    >> Share

    January 2024
  42. VAN BEEK DJ, Van Den Heede K, Rinkes IB, Norlen O, et al
    Surgery for advanced pancreatic neuroendocrine neoplasms: recommendations based on a consensus meeting of the European Society of Endocrine Surgeons (ESES).
    Br J Surg. 2024;111:znae017.
    >> Share

  43. LARSSON P, Soreide K
    Surgery for oligometastatic pancreatic cancer: next frontier?
    Br J Surg. 2024;111:znad419.
    >> Share

  44. OMIYA K, Maekawa A, Oba A, Inoue Y, et al
    A proposal of ABCD metastasectomy criteria for synchronous/metachronous metastatic pancreatic cancer in the era of multidisciplinary treatment.
    Br J Surg. 2024;111:znad417.
    >> Share


  45. Pancreatic surgery outcomes: multicentre prospective snapshot study in 67 countries.
    Br J Surg. 2024;111:znad330.
    >> Share

    December 2023
  46. ONNEKINK AM, Michiels N, Klatte DCF, Oldenburg L, et al
    Surgical outcomes after pancreatic surgery in patients with a germline CDKN2A/p16 pathogenic variant under surveillance.
    Br J Surg. 2023 Dec 29:znad430. doi: 10.1093.
    >> Share

  47. HALL LA, Powell-Brett S, Halle-Smith J, Ward L, et al
    Pancreatic exocrine insufficiency after non-pancreatic upper gastrointestinal surgery: meta-analysis.
    Br J Surg. 2023 Dec 8:znad369. doi: 10.1093.
    >> Share

    November 2023
  48. KIRKEGARD J, Ladekarl M, Johannsen IR, Mortensen F, et al
    Effect of adjuvant chemotherapy after pancreatectomy in patients with node-negative pancreatic cancer: target trial emulation.
    Br J Surg. 2023 Nov 25:znad398. doi: 10.1093.
    >> Share

  49. SCHLAPFER M, Schadde E, Braun J, Soll C, et al
    Effect of volatile versus total intravenous anaesthesia on circulating tumour cells after pancreatic adenocarcinoma resection: multicentre randomized clinical trial.
    Br J Surg. 2023 Nov 14:znad357. doi: 10.1093.
    >> Share

    October 2023
  50. BOAG KF, Britton E, Knight SR, Coe PO, et al
    Definition and management of intra-abdominal metachronous oligometastatic pancreatic cancer: a systematic review.
    Br J Surg. 2023 Oct 31:znad338. doi: 10.1093.
    >> Share

  51. UMANS DS, Timmerhuis HC, Anten MGF, Bhalla A, et al
    Prospective multicentre study of indications for surgery in patients with idiopathic acute pancreatitis following endoscopic ultrasonography (PICUS).
    Br J Surg. 2023 Oct 9:znad318. doi: 10.1093.
    >> Share

    July 2023
  52. DOPPENBERG D, van Dam JL, Han Y, Bonsing BA, et al
    Predictive value of baseline serum carbohydrate antigen 19-9 level on treatment effect of neoadjuvant chemoradiotherapy in patients with resectable and borderline resectable pancreatic cancer in two randomized trials.
    Br J Surg. 2023 Jul 13:znad210. doi: 10.1093.
    >> Share

    June 2023
  53. STRAND K, Moller JH
    Fluid treatment in acute pancreatitis: a careful balancing act.
    Br J Surg. 2023 Jun 16:znad155. doi: 10.1093.
    >> Share

  54. MAGGINO L, Malleo G, Crippa S, Belfiori G, et al
    Pathological staging in postneoadjuvant pancreatectomy for pancreatic cancer: implications for adjuvant therapy.
    Br J Surg. 2023 Jun 1:znad146. doi: 10.1093.
    >> Share

  55. AMMER-HERRMENAU C, Lingens CHM, Ratei CS, Heuer C, et al
    Whole 16S rRNA sequencing of the oral microbiome predicts postoperative pancreatic fistula: prospective observational cohort study.
    Br J Surg. 2023 Jun 1:znad129. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016